CompletedPhase 3NCT01940094
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Studying Granulomatosis with polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Peter A Merkel, MD, MPH, MD, MPHUniversity of Pennsylvania
- Intervention
- 5 mg Prednisone(drug)
- Enrollment
- 159 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2024
Study locations (9)
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- University of Utah, Salt Lake City, Utah, United States
- St. Joseph's Healthcare, Hamilton, Ontario, Canada
- Mount Sinai Hospital, Toronto, Ontario, Canada
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Office of Rare Diseases (ORD) · National Center for Advancing Translational Sciences (NCATS) · Rare Diseases Clinical Research Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01940094 on ClinicalTrials.govOther trials for Granulomatosis with polyangiitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06940661Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03919435TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With PolyangiitisUniversity of Pennsylvania
- ACTIVE NOT RECRUITINGPHASE3NCT01933724The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachUniversity of South Florida